Detalhe da pesquisa
1.
Pseudotyped Viruses for Influenza.
Adv Exp Med Biol
; 1407: 153-173, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920696
2.
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.
Front Immunol
; 14: 1118523, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911730
3.
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.
Vaccines (Basel)
; 10(9)2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146598
4.
AutoPlate: Rapid Dose-Response Curve Analysis for Biological Assays.
Front Immunol
; 12: 681636, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35222351
5.
Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies.
Front Immunol
; 12: 661379, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108964
6.
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection.
Vaccines (Basel)
; 9(7)2021 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358157
7.
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity.
Front Immunol
; 11: 627, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32547534